BindingDB

null

SMILES OC(=O)c1ccc(OCCn2ccnc2)cc1

InChI Key InChIKey=XQGZSYKGWHUSDH-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 7962

Glutaminyl-peptide cyclotransferase(Homo sapiens (Human))
Probiodrug AG

BDBM7962(4-(2-Imidazol-1-yl-ethoxy)-benzoic acid; hydrochlo...)copy SMILEScopy InChI

Ki: 2.30E+3nMAssay Description:QC activity was evaluated fluorometrically using Gln-AMC as substrate, and pyroglutamyl peptidase as the auxiliary enzyme. After conversion of Gln-AM...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase CHEMBL DrugBank MCE
PC cid PC sid Patents Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2513WDSPubMed

Targets 6 ▿
- Thromboxane-A synthase 22
- Cytochrome P450 11B1, mitochondrial 3
- Prostacyclin synthase 3
- Prostaglandin G/H synthase 1/2 3
- Glutaminyl-peptide cyclotransferase 1
- Bile salt export pump 1
Publications 22 ▿
- J Med Chem 29: 342-6 (1986) 4
- J Med Chem 29: 1643-50 (1986) 4
- J Med Chem 28: 1427-32 (1985) 4
- J Med Chem 32: 1265-72 (1989) 3
- J Med Chem 43: 4437-45 (2000) 1
- J Med Chem 30: 185-93 (1987) 1
- J Med Chem 30: 1036-40 (1987) 1
- J Med Chem 34: 1790-7 (1991) 1
- J Med Chem 29: 1637-43 (1986) 1
- J Med Chem 36: 2964-72 (1993) 1
- Drug Metab Dispos 40: 2332-41 (2012) 1
- J Med Chem 32: 1842-60 (1989) 1
- J Med Chem 29: 523-30 (1986) 1
- J Med Chem 30: 1812-8 (1987) 1
- J Biol Chem 278: 49773-9 (2003) 1
- J Med Chem 30: 1588-95 (1987) 1
- J Med Chem 24: 1139-48 (1982) 1
- J Med Chem 33: 646-52 (1990) 1
- J Med Chem 38: 1608-28 (1995) 1
- J Med Chem 30: 2277-83 (1988) 1
- J Med Chem 29: 816-9 (1986) 1
- J Med Chem 43: 1841-51 (2000) 1
Institutions 13 ▿
- [TBA] 19
- [Sankyo Co., Ltd.] 3
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
- [Wyeth Research UK, Medical Research Division of American Cyanamid Company, ZENECA Pharmaceuticals, Roche Research Center, CIBA-GEIGY Corporation, Universitat des Saarlandes, Searle Research and Development, Farmitalia Carlo Erba, Probiodrug AG, AstraZeneca, University of the Saarland] 1
Affinity: 3 to 1.0E+6 nM▿
- Ki 1
- IC50 32
- Affinity ≤ nM
Xtal structures: 0
Docked structures: 0
Catalog Cmpds: 1